We have modified and applied to selected outpatients the transvenous approach to correction of patent ductus arteriosus (PDA) with the Rashkind PDA Occluder. Modifications included establishing the diagnosis and PDA anatomy before catheterization with echocardiography. The sedation/anesthetic regimen was altered to meet the needs with respect to transcatheter PDA closure rather than diagnostic cardiac catheterization. Anticoagulation was avoided. A strategy for management of pin entrapment in the foam was devised. Residual trans-PDA flow after umbrella placement was temporarily occluded with balloon-tipped catheters. These modifications were used in 23 consecutive patients with uncomplicated PDA. Closure was successful in each child. Nineteen of 23 patients were discharged on the day of the procedure. No serious complications were encountered.
IN 1939, Gross and Hubbard1 began the era of congenital heart surgery when they reported the first successful ligation of a patent ductus arteriosus (PDA). The 7-year-old patient, who had an uneventful postoperative recovery, was hospitalized at the Children's Hospital in Boston for a total of 22 days; 6 hospital days because of "general interest" in the case. Surgical management of the PDA has since been highly refined to a very safe and effective procedure, with the average hospitalization now lasting about 1 week.
In recent years alternative methods of PDA closure have been investigated. In 1967 Porstmann et al. 2 introduced a transvascular closure technique (via cutdown); more recently, Rashkind and Cuaso3 described use of a double umbrella device introduced percutaneously to achieve closure. Subsequently, Bash and Mullins4 modified Rashkind's technique such that it could be accomplished by a transvenous percutaneous approach. Recent data on transcatheter closure indicate a success rate of about 65%; Rashkind et al.5 have noted a clinical success rate of about 84% in their most recent clinical study. We have further modified the transvenous approach to achieve successful outpatient closure of a PDA reliably and safely.
Methods
Preliminary studies. Based on initial animal studies,6 our first 12 procedures in children were performed transvenously on an inpatient basis. Informed consent was obtained from the patient and /or the patient's parents. The FDA protocol for transcatheter closure of PDA was approved by the Committee of Clinical Investigation at the Children's Hospital. We used our standard sedation technique of premedication with a meperidine compound (Breon Laboratories), local anesthetic, and supplemental sedation (morphine, diazepam) as needed. Patients were given heparin (100 units/kg) intravenously, several sets of hemodynamic data were obtained, multiple aortograms were performed with large arterial catheters to determine ductal anatomy, and ductal closure was then attempted by a modified transvenous long-sheath approach. 6 These initial procedures were lengthy (3 to 4 hr total duration) and the success rate (67%) was similar to that previously reported. Ductal closure was only partial in two of the 12 patients, due perhaps to increased PDA flow and/or systemic anticoagulation. Patient restlessness, incomplete sedation, and snaring of the umbrella foam by the guidewire in another two children resulted in embolization of the umbrella device into the left pulmonary artery. Retrieval of the device in these two patients was accomplished uneventfully at the time of surgical ligation of the PDA. Based on our animal studies and these initial clinical experiences, we modified our technique in the following ways: (1) The diagnosis and PDA anatomy were established before catheterization. (2) The sedation/anesthetic regimen was altered to meet the needs with respect to transcatheter PDA closure rather than those of diagnostic cardiac catheterization. (3) Systemic anticoagulation was avoided. (4) A strategy for management of pin entrapment in the foam was devised. (5) Residual trans-PDA flow after umbrella placement was temporarily occluded with balloon-tipped catheters. These modifications were then used in 23 consecutive patients with uncomplicated PDA.
Procedure. All children over 6 kg with an apparent PDA underwent complete examination and Doppler echocardiography as outpatients. Those with an isolated, restrictive (i.e., without pulmonary hypertension) PDA of less than 10 mm in diameter and in the typical location were offered either surgical ligation or transvascular closure in the cardiac catheterization CIRCULATION THERAPY AND PREVENTION-CONGENITAL HEART DISFASE laboratory on an outpatient basis. One child with a nonrestrictive PDA and pulmonary vascular disease was hospitalized before and after a combined diagnostic and interventional catheterization (successful) for assessment of pulmonary resistance.
Twenty-three patients opted for outpatient transcatheter closure; they were examined in the cardiac clinic the day before closure. Ductal anatomy was assessed with two-dimensional, Doppler, and color flow echocardiography.
The patients reported to ambulatory surgery the next morning, where they were premedicated with morphine (0.1 to 0.2 mg/kg iv or im). After transfer to the catheterization laboratory, the groin was prepared and infiltrated with local anesthetic. The femoral vein was cannulated with a 7F sheath, and the artery was cannulated with a No. 4F (patient less than 20 kg) or No. 5F ultrathin-walled Teflon pigtail catheter.7 Catheters were flushed with heparinized saline, but heparin was not administered. Right and left heart catheterization were rapidly performed with the patient awake, sedated, and breathing room air spontaneously. Care was taken to leave the arterial catheter in the descending aorta whenever possible. The precise size, configuration, and location of the PDA were determined via a retrograde aortogram. Catheter manipulation in the duct (and consequent ductal spasm) was avoided before aortography. A No. 7F balloon and end-hole catheter and/or 0.038 straight guidewire were then advanced from the main pulmonary artery across the PDA into the aorta. The patient was then anesthetized with intravenous ketamine and the catheter was removed over a 260 cm long, 0.038 inch guidewire and the groin was predilated with a dilator one French size larger than the long sheath. The Rashkind PDA occluder with either the knuckle/eye or pin/pin mechanism was used for PDA occlusion (USCI, Billerica, MA). For small PDAs (3 mm or less), a No. 8F long sheath and the 12 mm umbrella were used; for larger PDAs (4 to 10 mm) we used a No. 11iF long sheath and the 17 mm umbrella. The curve on the long sheaths was partially straightened to about 90 degrees with use of steam.
The sheath and dilator were advanced across the PDA over the guidewire into the aorta. The precise PDA position was again confirmed after an injection of contrast by hand through the long sheath or pigtail; we have found that transvenous placement of a long sheath through the PDA can distort the ductal position as much as 5 to 8 mm. The patient was then anesthetized (1 mg/kg iv ketamine). After soaking the umbrella foam disks in topical thrombin for 5 to 10 min, the umbrella was loaded and advanced to the end of the sheath as previously described.4 6 8 With the center of the double umbrella held at the aortic end of the duct, the long sheath was withdrawn until only the distal arms opened fully in the periductal aorta. The entire system was withdrawn until the distal arms flexed inward; the umbrella position was held constant and the sheath was withdrawn until the proximal arms opened (figure 1). The fully sprung (but unreleased) device was gently moved back and forth to confirm correct position, and then released. Any ensnarement of the release wire in the foam disks was managed by pinning the umbrella with the long sheath against the pulmonary end of the duct, allowing the wire tip to be safely freed ( figure 2 ). Immediately after release of the umbrella, a test aortogram was performed with the aortic pigtail catheter; if more than trivial ductal shunting persisted, the delivery catheter was removed and replaced with a No. 7F balloon end-hole catheter. This catheter was advanced to the pulmonary end of the PDA, and the inflated balloon was "pressed" against the umbrella for 10 to 15 min to reduce flow and promote PDA thrombosis (figure 3).
After emergence from anesthesia each patient was admitted to the recovery area. A chest x-ray was obtained 4 hr later to confirm device position. The puncture sites, pulses, and vital signs were monitored routinely, and children were discharged the same day when awake, alert, drinking fluids, and ambulating appropriately for age. Each patient was examined at a follow-up (1 to 6 months).
Results
We attempted 23 consecutive outpatient procedures (April 1986 to August 1987) in children ranging from 1 to 15 years of age (table 1). As judged by absence of a PDA murmur on discharge and a 1 to 6 months follow-up, closure was successful in each child. Technical observations. Only one umbrella was required to close the PDA in 21 of 23 patients; in two patients the initial expansion of the distal arms occurred in the pulmonary end of the PDA (due to unrecognized posterior displacement of the PDA by the sheath, see above). In each, the umbrella was retrieved without complication, although in one patient the umbrella became lodged in the groin fascia during retrieval, requiring a small (1 cm) local incision. Closure was then achieved in both patients with use of a second umbrella.
In two children the wire snared in the foam after release; in each, the tip was easily dislodged by first pinning the umbrella against the pulmonary artery (see figure 2 ). Angiographic observations. Aortography (1 ml/kg) performed at the end of the procedure confirmed complete PDA occlusion in 15 of 23 cases. In seven children, contrast sifted through the superior part of the device into the main pulmonary artery, although contrast was not visible in the branch pulmonary arteries. In one child (with a large, 7 mm PDA) contrast could be seen in the main pulmonary artery, and faintly in the right and left; at the 1 month follow-up, there was no clinical evidence of a PDA.
Clinical, anesthetic observations. The average procedure duration was 95 min from initial hemodynamic sample to catheter removal. Follow-up chest x-rays were unremarkable and showed no migration of the device or other complicating features.
Nineteen of the 23 patients were discharged home later during the day of the procedure and did not require hospital admission. Two patients remained in the hospital overnight for social reasons unrelated to the pro-CIRCULATION cedure. A diminished pedal pulse several hours after the procedure necessitated intravenous heparin therapy overnight in another two patients, but both were discharged the following morning with normal lower extremity pulses.
The amount of ketamine required for anesthesia ranged from 1.5 to 5 mg/kg. Small supplemental doses of diazepam were administered in three older patients to aid in emergence from ketamine, but no emergence delirium was observed. Transient vomiting after the procedure occurred in five patients, but protracted vomiting was not observed and did not prevent discharge in any patient.
Discussion
The surgical ligation of the PDA is safe, effective, and requires about 1 week of hospitalization. Transcatheter plug closure, a technique confined largely to the older child or adult, has enjoyed considerable suc-cess2; of interest, late follow-up of 208 patients so treated has revealed no episodes of endocarditis.9 Although the experience to date is limited, the technique of transvascular Rashkind umbrella closure of the PDA appears promising. Initial concerns about late migration of umbrella devices have proven unfounded. In the current literature, imprecision in device delivery, wire snagging in the foam, and incomplete closure have resulted in clinical success (i.e., absence of typical murmurs) rates of 65% to 85%.3-5 This relatively low success rate when compared with surgical closure has inhibited enthusiasm for widespread use of this technique.
The purpose of this article is to describe several technical modifications in method of placement of the Rashkind PDA occluder and the results of use of this modified technique. These changes include an anesthetic regimen designed to facilitate outpatient PDA closure, the use of small-bore retrograde arterial catheters to allow frequent angiographic assessment of ductal position (especially after placement of the long transvenous sheath after initial placement of the umbrella) and patency, the avoidance of systemic anticoagulation, the use of the long sheath to "pin" the umbrella against the pulmonary artery to reverse wire ensnarement, the soaking of the umbrella foam in topical thrombin before loading, and the use of an inflated balloon to "tamponade" residual PDA flow and promote its closure. These modifications have, we believe, contributed to clinically successful transcatheter PDA closure in 23 consecutive children with restrictive PDAs.
This report also serves to illustrate the degree to which cardiac care can be streamlined as a result of planning and advancing technology. The diagnosis in these children was established with considerable accuracy, noninvasively, at the time of outpatient evaluation. Selection procedures were used at the time to identify patients who required minimal invasive diagnostic study. Techniques were designed to obviate the need for systemic anticoagulation or large arterial catheters, thus reducing the potential for vascular trauma of late complications. Preliminary studies indicated that only a brief period of patient immobility was needed and an anesthetic regimen was constructed that produced the required control, minimal late morbidity, and excellent short-term recovery. The use of morphine premedication and ketamine anesthesia provided excellent analgesia and amnesia, although the potential for airway compromise, as in any anesthetized patient, and the technical demands on the cardiologists during the procedure itself dictated careful attention by a pediatric anesthesiologist. The successful surgical ligation of a PDA introduced a therapy that would remain the standard for 59 years. This same lesion was the first cardiac defect to be closed by transcatheter techniques. As a result of both advancing technology and limited health care resources, a procedure has been developed that can correct the same cardiac lesion on an outpatient basis. Although increased use of outpatient PDA closure may be anticipated because of these improved short-term results, the ultimate utility of this technique will be determined after long-term study of rates of late recanalization and endocarditis.
